Weight Loss

What to Look for in a Protein Powder?

Besides a balanced diet, many individuals opt to include supplements as part of their daily food intake. Protein powder is one such supplement which has become increasingly popular over recent years, with many users who want to achieve weight loss and muscle growth.

Weight Loss After Bariatric Surgery

Cachexia and Cancer

Military Diet: Health Risks

How Oral GLP-1 Drugs Work For Weight Loss

Cachexia / Wasting Syndrome

Vegetarian Diets for Weight Loss

The Natural Molecule That Could Rival Ozempic

Does Cinnamon Help with Weight Loss?

How Does Semaglutide Work to Lose Weight?

Circadian Rhythm and Weight Loss

Oral GLP-1 Pills for Weight Loss: How Orforglipron Works

See more featured articles »

GLP-1 and Diet: Evidence-Based Strategies for Better Weight Loss

Wegovy: A Breakthrough in Weight Loss?

Is a Hypocaloric Diet Safe and Effective for Long-Term Health?

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Is Cottage Cheese Good for Weight Loss? Evidence from Clinical Studies

Who Should Take Weight Loss Injections, and Who Shouldn’t?

Unexplained Weight Loss: When It Might Signal a Health Problem

Semaglutide and Weight Loss in Menopause

Mental Health Disorders, Weight Gain, and Exercise

What Is Cancer Cachexia? Causes, Symptoms, Diagnosis, and Treatment

Latest Weight Loss News and Research

GLP-1 medications may improve long-term health for people with peripheral artery disease

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes who also had narrowed leg arteries associated with PAD (peripheral artery disease), according to new, independent research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

1 Jul 2026

Obesity may account for up to one in four polypharmacy cases

The study reveals obesity's role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance quality of life for older adults.

1 Jul 2026

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However, among adults without type 2 diabetes, tirzepatide was linked to higher recorded hazards of anxiety and insomnia than semaglutide, underscoring the need for cautious monitoring.

1 Jul 2026

Pharmacy expert calls for hybrid digital-human models in NHS healthcare

A pharmacy academic from Kingston University has provided special expertise to the UK Parliament on two key Health and Social Care Committee inquiries.

30 Jun 2026

Simple blood test could identify the most effective obesity drug

Fasting blood tests measuring GLP-1 and GIP levels may predict obesity treatment response to semaglutide and tirzepatide, enhancing personalized therapy.

29 Jun 2026

Scientists uncover immune mechanisms driving rare gastrointestinal disorder

A collaborative team led by Dr. Jingnan Li and Dr. Ji Li at Peking Union Medical College Hospital, together with Associate Professor Xiaohuan Guo at Tsinghua University and Academician Ye-Guang Chen at Tsinghua University School of Life Sciences, published a study in Volume 2, article number 28 of the journal Immunity & Inflammation on June 17, 2026.

26 Jun 2026

Single DNA injection provides long-lasting weight loss in mouse study

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can produce weight loss and blood glucose control in murine models that lasts up to 10 times as long as incretin-mimicking drugs like Ozempic and Wegovy.

26 Jun 2026

Unexplained skin darkening leads to life-saving Addison's disease diagnosis

A 24-year-old woman presented with two years of unexplained darkening of her hands, feet, gums, and tongue.

26 Jun 2026

Semaglutide approval drove a surge in GLP-1 poison center exposures

Following semaglutide's approval, poison center reports of GLP-1 RA exposures doubled, revealing critical trends in patient safety and healthcare utilization.

26 Jun 2026

Exercise, not liraglutide alone, drives vascular gains after obesity-related weight loss

A prespecified secondary analysis of the S-LiTE trial found that regular exercise reduced carotid artery wall thickness and circulating levels of inflammatory cytokines in adults with obesity who had already achieved substantial diet-induced weight loss. Liraglutide alone did not significantly improve these vascular or inflammatory markers, while exercise plus liraglutide also improved endothelial function biomarkers.

25 Jun 2026

Bariatric surgery linked to higher risk of developing alcohol problems

Your body absorbs alcohol much more rapidly after bariatric surgery. Patients need to know this when they choose the kind of surgery they will have.

25 Jun 2026

Concerns about weight regain after yo‑yo dieting are largely unfounded, review shows

Many people experience fluctuations in body weight throughout their lives, and so‑called yo‑yo dieting has long been considered a health risk – in some cases even more harmful than remaining overweight.

24 Jun 2026

Lost weight is less likely to return when exercise follows obesity treatment

A systematic review and meta-analysis of 11 randomized controlled trials found that exercise during the post-weight-loss maintenance phase reduced weight regain by an average of 2.81 kg compared with control groups. Evidence for fat-mass reduction remained inconclusive, highlighting the need for longer, standardized trials with better adherence and body-composition monitoring.

24 Jun 2026

Strength training plus cardio cuts type 2 diabetes risk the most

A 20-year prospective cohort study of 143,715 US healthcare professionals found that long-term resistance training was associated with a substantially lower risk of type 2 diabetes. The lowest risk was seen among participants who combined regular resistance training with adequate aerobic activity and limited TV viewing.

23 Jun 2026

Circadian rhythm influences calorie burning after eating

Han-Chow Koh, PhD, and Frank A.J.L. Scheer, PhD, of the Medical Chronobiology Program at the Division of Sleep and Circadian Medicine in the Mass General Brigham Department of Medicine, are the co-lead and senior author, respectively, of a paper published in Metabolism, "Constant-routine protocol reveals an endogenous circadian rhythm in diet-induced thermogenesis with a peak in the biological morning."

23 Jun 2026